Literature DB >> 10747817

NNRTIs-a new class of drugs for HIV.

S M Drake1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10747817     DOI： 10.1093/jac/45.4.417

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.

Authors:  Joseph Rebehmed; Florent Barbault; Cátia Teixeira; François Maurel
Journal:  J Comput Aided Mol Des       Date:  2008-05-28       Impact factor: 3.686

2.  Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.

Authors:  Mohammad Hassam; Adriaan E Basson; Dennis C Liotta; Lynn Morris; Willem A L van Otterlo; Stephen C Pelly
Journal:  ACS Med Chem Lett       Date:  2012-05-02       Impact factor: 4.345

3.  Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.

Authors:  Elena N Peletskaya; Alex A Kogon; Steven Tuske; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 4.  CNS Neurotoxicity of Antiretrovirals.

Authors:  Tyler Lanman; Scott Letendre; Qing Ma; Anne Bang; Ronald Ellis
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-10       Impact factor: 4.147

5.  New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.

Authors:  Stefano Rusconi; Mirko Lo Cicero; Ottavia Viganò; Francesca Sirianni; Elisabetta Bulgheroni; Stefania Ferramosca; Andrea Bencini; Antonio Bianchi; Lidia Ruiz; Cecilia Cabrera; Javier Martinez-Picado; Claudiu T Supuran; Massimo Galli
Journal:  Molecules       Date:  2009-05-22       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.